enzymes

This tag is associated with 4 posts

IFF acquires DuPont’s Nutrition and Biosciences business

International Flavors and Fragrances (IFF) announced yesterday its acquisition of DuPont’s Nutrition and Biosciences (N&B) business in a Reverse Morris Trust Transaction*. The deal values the combined company at $45.4 billion on an enterprise value basis, reflecting a value of $26.2 billion for the N&B business based on IFF’s share price as of 13 December … Continue reading »

Dyadic sells enzyme assets to DuPont

The blog is trying to catch up to several big news announced earlier this month and one of them is DuPont Industrial Biosciences’ purchase of Dyadic International’s enzyme and technology assets including its C1 platform, a fungal expression technology for producing enzymes. DuPont has become the second largest global enzymes producer next to Novozymes after its acquisition … Continue reading »

DuPont’s cellulosic ethanol tech in China

DuPont announced a licensing deal with Jilin Province New Tianlong Industry Co. Ltd. (NTL) for the use of DuPont’s cellulosic ethanol technology and its Accelerase enzymes for the production of renewable biofuel from leftover biomass on Jilin Province’s corn farms. This project aims to develop China’s largest cellulosic ethanol manufacturing plant to be located in … Continue reading »

Recent biorefinery deals

Abengoa has been selected by Fulcrum BioEnergy to build its first biorefinery, worth $200m, to be located in the Tahoe-Reno Industrial Center, Nevada (USA). The facility will use gasification technology to convert municipal solid waste (MSW) into syncrude that will be upgraded into jet fuel. Abengoa will be responsible for the turnkey execution of the … Continue reading »

Archives

Meta